Epidemiology and prognosis of brain metastases

Surgical Neurology International

Volumn 4, Issue SUPPL4, 2013, Pages

  Stelzer, Keith ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Biomarkers; brain metastasis; prognosis model

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BRAIN METASTASIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL FUNCTION; HUMAN; PATIENT SELECTION; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

EID: 84877934599     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.111296     Document Type: Article

References (57)

1. Agarwal JP, Wadasadawala T, Munshi A, Chadda P, Apsani R, Upasani M, et al. Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy. Clin Oncol 2010;22:837-43
2. Agboola O, Benoit B, Cross P, Da Silva V, Esche B, Lesiuk H, et al. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 1998;42:155-9
3. Arora S, Ranade AR, Tran HL, Nasser S, Sridhar S, Korn RL. MicroRNA-328 is associated with non-small cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer 2011;129:2621-31
4. Auperin A, Arriagada R, Pignon JP, Le Pechoux C, Gregor A, Stephens RJ, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;34:476-84
5. Bajard A, Westeel V, Dubiez A, Jacoulet P, Pernet D, Dalphin JC, et al. Multivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma. Lung Cancer 2004;45:317-23
6. Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, et al. A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol 2012;14:910-8
7. Bedikian AY, Wei C, Detry M, Kim KB, Papadopoulos NE, Hwu WJ, et al. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma. Am J Clin Oncol 2011;34:603-10
8. Berghoff A, Bago-Horvath Z, De Vries C, Dubsky P, Pluschnig U, Rudas M, et al. Brain metastases free survival differs between breast cancer subtypes. Br J Cancer 2012;106:440-6
9. Brady LW, Mancall EL, Lee DK, Neff B, Shockman AT, Faust DS, et al. Radiation therapy for intracranial metastatic neoplasia. Radiol Clin Biol 1974;43:40-7
10. Chiou SM. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients′ survival after Gamma Knife radiosurgery. Int J Radiat Oncol Biol Phys 2010;78:1156-62
11. Chu FCH, Hilaris BB. Value of radiation therapy in the management of intracranial metastases. Cancer 1961;14:577-81
12. Claude L, Perol D, Ray-Coquard I, Petit T, Blay JY, Carrie C, et al. Lymphopenia: A new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol 2005;76:334-9
13. Counsell CE, Collie DA, Grant R. Incidence of intracranial tumors in the Lothian region of Scotland 1989-1990. J Neurol Neurosurg Psychiatr 1996;61:143-50
14. Eichler AF, Kahle KT, Wang DL, Joshi VA, Willers H, Engelman JA, et al. EGFR mutation status and survival after diagnosis of brain metastases in nonsmall cell lung cancer. Neuro Oncol 2010;12:1193-9
15. Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011;117:1697-703
16. Feld R, Rubinstein LV, Weisenberger TH, Sites of recurrence in resected stage I non-small-cell lung cancer: A guide for future studies. J Clin Oncol 1984;2:1352-8
17. Figlin RA, Piantadosi S, Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med 1988;318:1300-5
18. Fogelholm R, Uutela T, Murros K. Epidemiology of central nervous system neoplasms. A regional survey in central Finland. Acta Neurol Scand 1984;69:129-36
19. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 2011;22:1-6
20. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51
21. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000;47:1001-6
22. Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L, et al. nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 2010;28:2032-7
23. Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, et al. Breast cancer with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol 2006;30:1097-104
24. Hubbs JL, Boyd JA, Hollis D, Chino JP, Saynak M, Kelsey CR. Factors associated with the development of brain metastases. Analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer 2010;116:5038-46
25. Jakola AS, Gulati S, Nerland US, Solheim O. Surgical resection of brain metastases: The prognostic value of the graded prognostic assessment score. J Neurooncol 2011;105:573-81
26. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43:795-803
27. Lang EF, Slater J. Metastatic brain tumors: Results of surgical and nonsurgical treatment. S Clin N Am 1964;44:865-72
28. Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen-Solal C, de Lalande B. Brain metastases from breast carcinoma: Validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. Int J Radiat Oncol Biol Phys 2007;69:839-45
29. Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. J Neurosurg 2011;114:769-79
30. Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, et al. Radiosurgery for treatment of brain metastases: Estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004;60:218-24
31. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9
32. Materljan E, Materljan B, Sepcic J, Tuskan-Mohar L, Zamolo G, Erman-Baldini I. Epidemiology of central nervous system tumors in Labin area, Croatia, 1974-2001. Croat Med J 2004;45:206-12
33. Meyners T, Heisterkamp C, Kueter JD, Veninga T, Stalpers LJ, Schild SE, et al. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: A retrospective analysis. BMC Cancer 2010;10:582
34. Movsas B, Bae K, Meyers C, Gore E, Bonner J, Sun A, et al. Phase III study of prophylactic cranial irradiation vs. observation in patients with stage III non-small-cell lung cancer: Neurocognitive and quality of life analysis of RTOG 0214. Proceedings of ASTRO. Int J Radiat Oncol Biol Phys 2009;75:S1
35. Nieder C, Astner ST, Andratschke NH, Marienhagen K. Postoperative treatment and prognosis of patients with resected single brain metastasis: How useful are established prognostic scores? Clin Neurol Neurosurg 2010;113:98-103
36. Nieder C, Marienhagen K, Geinitz H, Grosu AL. Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma? J Cancer Res Ther 2011;7:47-51
37. Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K. Prognostic factors in brain metastases: Should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 2000;46:297-302
38. Niwinska A, Murawska M. New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2012;82:2065-71
39. Order SE, Hellman S, Von Essen CF, Kligerman MM. Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology 1968;91:149-53
40. Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 2006;17:935-44
41. Rades D, Dunst J, Schild SE. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008;84:251-5
42. Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J, et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys 2011;80:1122-7
43. Slotman B, Faivre-Finn C, Karmer G, Rankin E, Snee M, Hatton M, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-72
44. Smedby KE, Brandt L, Backlund ML, Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 2009;101:1919-24
45. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510-4
46. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberg D, et al. Diagnostic-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010;77:655-661
47. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 2012;82:2111-7
48. Stark AM, Stohring C, Hedderich J, Held-Feindt J, Mehdorn HM. Surgical treatment for brain metastases: Prognostic factors and survival in 309 patients with regard to patient age. J Clin Neurosci 2011;18:34-8
49. Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, et al. Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 2010;102:1213-8
50. Sundaresan P, Yeghiaian-Alvandi R, Gebski V. Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer. J Med Imaging Radiat Oncol 2010;54:69-75
51. Tendulkar RD, Liu SW, Barnett GH, Vogelbaum MA, Toms SA, Jin T, et al. RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 2006;66:810-7
52. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006;107:696-704
53. The Ludwig Lung Cancer Study Group, Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 1987;205:67-71
54. Villa S, Weber DC, Moretones C, Manes A, Combescure C, Jove J, et al. Validation of the new graded prognostic assessment scale for brain metastases: A multicenter prospective study. Radiat Oncol 2011;6:23
55. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985;35:219-26
56. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, et al. Radiosurgery for brain metastases: A score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000;46:1155-61
57. Zakrzewski J, Geraghty LN, Rose AE, Christos PJ, Mazumdar M, Polsky D, et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastasis and post-brain metastasis survival. Cancer 2011;117:1711-20